National Black Nurse Practitioner Association

GlaxoSmithKline (GSK) Presents: BENLYSTA (belimumab)

Posted about 3 years ago

This announcement has 2 attachments:

BENLYSTA (belimumab) is the first and only FDA -Approved Treatment for both Systemic Lupus Erythematosus (SLE) and Lupus Nephritis.  Please see and share attached QR codes with patients and/or persons interested. Information is also available at benlysta.com